# Ozempic and other GLP‑1 drugs linked with lower epilepsy risk in people with type 2 diabetes

**Category:** Health
**Source:** [https://www.sciencedaily.com/releases/2025/12/251213081234.htm](https://www.sciencedaily.com/releases/2025/12/251213081234.htm)
**Publisher:** ScienceDaily
**Published:** 2025-12-13
**Scraped (UTC):** 2025-12-21T18:55:20+00:00

## Summary
A new analysis suggests GLP‑1 receptor agonists used for type 2 diabetes may be associated with reduced incidence of epilepsy compared with DPP‑4 inhibitors, indicating potential neurological benefits.

## Full Article
*(Article text could not be extracted. Visit source link above.)*

---

*Content scraped from public sources with attribution. Users assume all risk.*  
*Auto-generated by [Perplexity News Tracker](https://github.com/myidkd1-coder/perplexity-news-tracker)*